{"entity":{"type":"insider","cik":"0001547658","url":"/insider/0001547658","json_url":"/insider/0001547658.json","name":"Baird William D III","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":37,"n_filings":31,"first":"2014-10-01","last":"2025-03-19","span_basis":"filed_date"},"name_variants":[{"name":"Baird William D III","source":"filing","n_filings":31,"first_seen":"2014-10-01","last_seen":"2025-03-19"}],"transactions":[{"id":4258829,"accession":"0001562180-25-002603","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-25-002603","line_url":"/filing/0001562180-25-002603#line-1","is_derivative":false,"issuer_cik":"0001547658","issuer_name":"2seventy bio, Inc.","issuer_ticker":"TSVT","issuer_name_source":null,"issuer_url":"/issuer/0001547658","owner_cik":"0001547658","owner_name":"Baird William D III","owner_display_name":"Baird William D III","owner_url":"/insider/0001547658","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5092.0,"shares_display":"5,092","price_per_share":4.945,"price_display":"4.94","price_state":"stated","total_value":25179.94,"total_display":"25,179.94","total_whole":"25,180","shares_owned_after":1121034.0,"shares_owned_after_display":"1,121,034","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-17","filed_date":"2025-03-19","scope":"insider"},{"id":4784190,"accession":"0001562180-25-000243","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-25-000243","line_url":"/filing/0001562180-25-000243#line-2","is_derivative":false,"issuer_cik":"0001547658","issuer_name":"2seventy bio, Inc.","issuer_ticker":"TSVT","issuer_name_source":null,"issuer_url":"/issuer/0001547658","owner_cik":"0001547658","owner_name":"Baird William D III","owner_display_name":"Baird William D III","owner_url":"/insider/0001547658","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":763.0,"shares_display":"763","price_per_share":2.7785,"price_display":"2.78","price_state":"stated","total_value":2119.9955,"total_display":"2,120.00","total_whole":"2,120","shares_owned_after":862126.0,"shares_owned_after_display":"862,126","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-06","filed_date":"2025-01-07","scope":"insider"},{"id":4784186,"accession":"0001562180-25-000243","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-25-000243","line_url":"/filing/0001562180-25-000243#line-1","is_derivative":false,"issuer_cik":"0001547658","issuer_name":"2seventy bio, Inc.","issuer_ticker":"TSVT","issuer_name_source":null,"issuer_url":"/issuer/0001547658","owner_cik":"0001547658","owner_name":"Baird William D III","owner_display_name":"Baird William D III","owner_url":"/insider/0001547658","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31718.0,"shares_display":"31,718","price_per_share":2.9359,"price_display":"2.94","price_state":"stated","total_value":93120.8762,"total_display":"93,120.88","total_whole":"93,121","shares_owned_after":862889.0,"shares_owned_after_display":"862,889","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-03","filed_date":"2025-01-07","scope":"insider"},{"id":2789115,"accession":"0001562180-24-000366","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-24-000366","line_url":"/filing/0001562180-24-000366#line-1","is_derivative":false,"issuer_cik":"0001547658","issuer_name":"2seventy bio, Inc.","issuer_ticker":"TSVT","issuer_name_source":null,"issuer_url":"/issuer/0001547658","owner_cik":"0001547658","owner_name":"Baird William D III","owner_display_name":"Baird William D III","owner_url":"/insider/0001547658","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1380.0,"shares_display":"1,380","price_per_share":3.7536,"price_display":"3.75","price_state":"stated","total_value":5179.968,"total_display":"5,179.97","total_whole":"5,180","shares_owned_after":161335.0,"shares_owned_after_display":"161,335","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-05","filed_date":"2024-01-09","scope":"insider"},{"id":3184693,"accession":"0001562180-24-000303","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-24-000303","line_url":"/filing/0001562180-24-000303#line-1","is_derivative":false,"issuer_cik":"0001547658","issuer_name":"2seventy bio, Inc.","issuer_ticker":"TSVT","issuer_name_source":null,"issuer_url":"/issuer/0001547658","owner_cik":"0001547658","owner_name":"Baird William D III","owner_display_name":"Baird William D III","owner_url":"/insider/0001547658","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33651.0,"shares_display":"33,651","price_per_share":3.8685,"price_display":"3.87","price_state":"stated","total_value":130178.8935,"total_display":"130,178.89","total_whole":"130,179","shares_owned_after":162715.0,"shares_owned_after_display":"162,715","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-03","filed_date":"2024-01-05","scope":"insider"},{"id":8688547,"accession":"0001562180-23-006558","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-23-006558","line_url":"/filing/0001562180-23-006558#line-1","is_derivative":false,"issuer_cik":"0001547658","issuer_name":"2seventy bio, Inc.","issuer_ticker":"TSVT","issuer_name_source":null,"issuer_url":"/issuer/0001547658","owner_cik":"0001547658","owner_name":"Baird William D III","owner_display_name":"Baird William D III","owner_url":"/insider/0001547658","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7031.0,"shares_display":"7,031","price_per_share":5.4865,"price_display":"5.49","price_state":"stated","total_value":38575.5815,"total_display":"38,575.58","total_whole":"38,576","shares_owned_after":196366.0,"shares_owned_after_display":"196,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-22","filed_date":"2023-08-24","scope":"insider"},{"id":7978145,"accession":"0001562180-23-006220","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-23-006220","line_url":"/filing/0001562180-23-006220#line-1","is_derivative":false,"issuer_cik":"0001547658","issuer_name":"2seventy bio, Inc.","issuer_ticker":"TSVT","issuer_name_source":null,"issuer_url":"/issuer/0001547658","owner_cik":"0001547658","owner_name":"Baird William D III","owner_display_name":"Baird William D III","owner_url":"/insider/0001547658","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6906.0,"shares_display":"6,906","price_per_share":6.1257,"price_display":"6.13","price_state":"stated","total_value":42304.0842,"total_display":"42,304.08","total_whole":"42,304","shares_owned_after":203397.0,"shares_owned_after_display":"203,397","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-03","filed_date":"2023-08-07","scope":"insider"},{"id":8021464,"accession":"0001562180-23-001427","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-23-001427","line_url":"/filing/0001562180-23-001427#line-1","is_derivative":false,"issuer_cik":"0001547658","issuer_name":"2seventy bio, Inc.","issuer_ticker":"TSVT","issuer_name_source":null,"issuer_url":"/issuer/0001547658","owner_cik":"0001547658","owner_name":"Baird William D III","owner_display_name":"Baird William D III","owner_url":"/insider/0001547658","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":637.0,"shares_display":"637","price_per_share":12.86,"price_display":"12.86","price_state":"stated","total_value":8191.82,"total_display":"8,191.82","total_whole":"8,192","shares_owned_after":210303.0,"shares_owned_after_display":"210,303","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-13","filed_date":"2023-02-15","scope":"insider"},{"id":8021395,"accession":"0001562180-23-000482","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-23-000482","line_url":"/filing/0001562180-23-000482#line-1","is_derivative":false,"issuer_cik":"0001547658","issuer_name":"2seventy bio, Inc.","issuer_ticker":"TSVT","issuer_name_source":null,"issuer_url":"/issuer/0001547658","owner_cik":"0001547658","owner_name":"Baird William D III","owner_display_name":"Baird William D III","owner_url":"/insider/0001547658","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1077.0,"shares_display":"1,077","price_per_share":10.6281,"price_display":"10.63","price_state":"stated","total_value":11446.4637,"total_display":"11,446.46","total_whole":"11,446","shares_owned_after":78797.0,"shares_owned_after_display":"78,797","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-11","filed_date":"2023-01-18","scope":"insider"},{"id":7977441,"accession":"0001562180-23-000356","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-23-000356","line_url":"/filing/0001562180-23-000356#line-1","is_derivative":false,"issuer_cik":"0001547658","issuer_name":"2seventy bio, Inc.","issuer_ticker":"TSVT","issuer_name_source":null,"issuer_url":"/issuer/0001547658","owner_cik":"0001547658","owner_name":"Baird William D III","owner_display_name":"Baird William D III","owner_url":"/insider/0001547658","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3222.0,"shares_display":"3,222","price_per_share":10.3347,"price_display":"10.33","price_state":"stated","total_value":33298.4034,"total_display":"33,298.40","total_whole":"33,298","shares_owned_after":79874.0,"shares_owned_after_display":"79,874","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-09","filed_date":"2023-01-11","scope":"insider"},{"id":6254513,"accession":"0001562180-22-005951","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-22-005951","line_url":"/filing/0001562180-22-005951#line-1","is_derivative":false,"issuer_cik":"0001547658","issuer_name":"2seventy bio, Inc.","issuer_ticker":"TSVT","issuer_name_source":null,"issuer_url":"/issuer/0001547658","owner_cik":"0001547658","owner_name":"Baird William D III","owner_display_name":"Baird William D III","owner_url":"/insider/0001547658","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4152.0,"shares_display":"4,152","price_per_share":16.2325,"price_display":"16.23","price_state":"stated","total_value":67397.34,"total_display":"67,397.34","total_whole":"67,397","shares_owned_after":83096.0,"shares_owned_after_display":"83,096","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-05","filed_date":"2022-08-08","scope":"insider"},{"id":6627143,"accession":"0001562180-22-005711","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-22-005711","line_url":"/filing/0001562180-22-005711#line-1","is_derivative":false,"issuer_cik":"0001547658","issuer_name":"2seventy bio, Inc.","issuer_ticker":"TSVT","issuer_name_source":null,"issuer_url":"/issuer/0001547658","owner_cik":"0001547658","owner_name":"Baird William D III","owner_display_name":"Baird William D III","owner_url":"/insider/0001547658","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4080.0,"shares_display":"4,080","price_per_share":13.8099,"price_display":"13.81","price_state":"stated","total_value":56344.392,"total_display":"56,344.39","total_whole":"56,344","shares_owned_after":87248.0,"shares_owned_after_display":"87,248","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-15","filed_date":"2022-07-19","scope":"insider"},{"id":6302816,"accession":"0001562180-22-001678","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-22-001678","line_url":"/filing/0001562180-22-001678#line-1","is_derivative":false,"issuer_cik":"0001547658","issuer_name":"2seventy bio, Inc.","issuer_ticker":"TSVT","issuer_name_source":null,"issuer_url":"/issuer/0001547658","owner_cik":"0001547658","owner_name":"Baird William D III","owner_display_name":"Baird William D III","owner_url":"/insider/0001547658","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":427.0,"shares_display":"427","price_per_share":14.78,"price_display":"14.78","price_state":"stated","total_value":6311.06,"total_display":"6,311.06","total_whole":"6,311","shares_owned_after":57578.0,"shares_owned_after_display":"57,578","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-17","filed_date":"2022-02-22","scope":"insider"},{"id":6759983,"accession":"0001562180-22-000411","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-22-000411","line_url":"/filing/0001562180-22-000411#line-1","is_derivative":false,"issuer_cik":"0001547658","issuer_name":"2seventy bio, Inc.","issuer_ticker":"TSVT","issuer_name_source":null,"issuer_url":"/issuer/0001547658","owner_cik":"0001547658","owner_name":"Baird William D III","owner_display_name":"Baird William D III","owner_url":"/insider/0001547658","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":896.0,"shares_display":"896","price_per_share":23.9078,"price_display":"23.91","price_state":"stated","total_value":21421.3888,"total_display":"21,421.39","total_whole":"21,421","shares_owned_after":58005.0,"shares_owned_after_display":"58,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-07","filed_date":"2022-01-11","scope":"insider"},{"id":4560362,"accession":"0001562180-21-001277","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-21-001277","line_url":"/filing/0001562180-21-001277#line-3","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":"0001547658","owner_name":"Baird William D III","owner_display_name":"Baird William D III","owner_url":"/insider/0001547658","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":693.0,"shares_display":"693","price_per_share":28.1613,"price_display":"28.16","price_state":"stated","total_value":19515.7809,"total_display":"19,515.78","total_whole":"19,516","shares_owned_after":35529.0,"shares_owned_after_display":"35,529","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-17","filed_date":"2021-02-18","scope":"insider"},{"id":4724898,"accession":"0001562180-21-001222","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-21-001222","line_url":"/filing/0001562180-21-001222#line-1","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":"0001547658","owner_name":"Baird William D III","owner_display_name":"Baird William D III","owner_url":"/insider/0001547658","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1216.0,"shares_display":"1,216","price_per_share":45.52,"price_display":"45.52","price_state":"stated","total_value":55352.32,"total_display":"55,352.32","total_whole":"55,352","shares_owned_after":21581.0,"shares_owned_after_display":"21,581","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-12","filed_date":"2021-02-17","scope":"insider"},{"id":4145110,"accession":"0001562180-21-000268","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-21-000268","line_url":"/filing/0001562180-21-000268","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":"0001547658","owner_name":"Baird William D III","owner_display_name":"Baird William D III","owner_url":"/insider/0001547658","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":949.0,"shares_display":"949","price_per_share":45.05348440463646,"price_display":"45.05","price_state":"stated","total_value":42755.7567,"total_display":"42,755.76","total_whole":"42,756","shares_owned_after":23194.0,"shares_owned_after_display":"23,194","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-06","filed_date":"2021-01-08","scope":"insider","n_lines":2},{"id":2617094,"accession":"0001562180-20-001319","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-20-001319","line_url":"/filing/0001562180-20-001319#line-1","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":"0001547658","owner_name":"Baird William D III","owner_display_name":"Baird William D III","owner_url":"/insider/0001547658","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1254.0,"shares_display":"1,254","price_per_share":90.6,"price_display":"90.60","price_state":"stated","total_value":113612.4,"total_display":"113,612.40","total_whole":"113,612","shares_owned_after":13746.0,"shares_owned_after_display":"13,746","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-13","filed_date":"2020-02-18","scope":"insider"},{"id":6804464,"accession":"0001209191-18-055422","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-055422","line_url":"/filing/0001209191-18-055422#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001547658","owner_name":"Baird William D III","owner_display_name":"Baird William D III","owner_url":"/insider/0001547658","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":12.2275,"price_display":"12.23","price_state":"stated","total_value":122275.0,"total_display":"122,275.00","total_whole":"122,275","shares_owned_after":117622.0,"shares_owned_after_display":"117,622","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-15","filed_date":"2018-10-17","scope":"insider"},{"id":9270730,"accession":"0001209191-18-055419","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-055419","line_url":"/filing/0001209191-18-055419#line-1","is_derivative":false,"issuer_cik":"0001547658","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001547658","owner_cik":"0001547658","owner_name":"Baird William D III","owner_display_name":"Baird William D III","owner_url":"/insider/0001547658","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":15.6292,"price_display":"15.63","price_state":"stated","total_value":156292.0,"total_display":"156,292.00","total_whole":"156,292","shares_owned_after":117622.0,"shares_owned_after_display":"117,622","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-02","filed_date":"2018-10-17","scope":"insider"},{"id":6236700,"accession":"0001209191-18-041621","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-041621","line_url":"/filing/0001209191-18-041621#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001547658","owner_name":"Baird William D III","owner_display_name":"Baird William D III","owner_url":"/insider/0001547658","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":15.6292,"price_display":"15.63","price_state":"stated","total_value":156292.0,"total_display":"156,292.00","total_whole":"156,292","shares_owned_after":107622.0,"shares_owned_after_display":"107,622","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-02","filed_date":"2018-07-05","scope":"insider"},{"id":6100196,"accession":"0001209191-18-023846","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-023846","line_url":"/filing/0001209191-18-023846#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001547658","owner_name":"Baird William D III","owner_display_name":"Baird William D III","owner_url":"/insider/0001547658","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":14.2648,"price_display":"14.26","price_state":"stated","total_value":142648.0,"total_display":"142,648.00","total_whole":"142,648","shares_owned_after":117622.0,"shares_owned_after_display":"117,622","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-02","filed_date":"2018-04-04","scope":"insider"},{"id":6656821,"accession":"0001209191-18-002055","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-002055","line_url":"/filing/0001209191-18-002055#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001547658","owner_name":"Baird William D III","owner_display_name":"Baird William D III","owner_url":"/insider/0001547658","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":14.7181,"price_display":"14.72","price_state":"stated","total_value":147181.0,"total_display":"147,181.00","total_whole":"147,181","shares_owned_after":95121.0,"shares_owned_after_display":"95,121","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-02","filed_date":"2018-01-04","scope":"insider"},{"id":5121895,"accession":"0001209191-17-057057","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-057057","line_url":"/filing/0001209191-17-057057#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001547658","owner_name":"Baird William D III","owner_display_name":"Baird William D III","owner_url":"/insider/0001547658","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":14.2533,"price_display":"14.25","price_state":"stated","total_value":570132.0,"total_display":"570,132.00","total_whole":"570,132","shares_owned_after":95121.0,"shares_owned_after_display":"95,121","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-12","filed_date":"2017-10-16","scope":"insider"},{"id":2786663,"accession":"0001209191-16-142451","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-142451","line_url":"/filing/0001209191-16-142451","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001547658","owner_name":"Baird William D III","owner_display_name":"Baird William D III","owner_url":"/insider/0001547658","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20500.0,"shares_display":"20,500","price_per_share":8.003648780487804,"price_display":"8.00","price_state":"stated","total_value":164074.8,"total_display":"164,074.80","total_whole":"164,075","shares_owned_after":35950.0,"shares_owned_after_display":"35,950","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-20","filed_date":"2016-09-22","scope":"insider","n_lines":2},{"id":8604549,"accession":"0001209191-15-071829","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-071829","line_url":"/filing/0001209191-15-071829#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001547658","owner_name":"Baird William D III","owner_display_name":"Baird William D III","owner_url":"/insider/0001547658","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15236.0,"shares_display":"15,236","price_per_share":16.7783,"price_display":"16.78","price_state":"stated","total_value":255634.1788,"total_display":"255,634.18","total_whole":"255,634","shares_owned_after":56575.0,"shares_owned_after_display":"56,575","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-21","filed_date":"2015-09-22","scope":"insider"},{"id":8885907,"accession":"0001209191-15-055750","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-055750","line_url":"/filing/0001209191-15-055750#line-4","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001547658","owner_name":"Baird William D III","owner_display_name":"Baird William D III","owner_url":"/insider/0001547658","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15235.0,"shares_display":"15,235","price_per_share":13.2627,"price_display":"13.26","price_state":"stated","total_value":202057.2345,"total_display":"202,057.23","total_whole":"202,057","shares_owned_after":56575.0,"shares_owned_after_display":"56,575","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-19","filed_date":"2015-06-23","scope":"insider"},{"id":8489896,"accession":"0001209191-15-042018","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-042018","line_url":"/filing/0001209191-15-042018#line-3","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001547658","owner_name":"Baird William D III","owner_display_name":"Baird William D III","owner_url":"/insider/0001547658","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24800.0,"shares_display":"24,800","price_per_share":10.8391,"price_display":"10.84","price_state":"stated","total_value":268809.68,"total_display":"268,809.68","total_whole":"268,810","shares_owned_after":6575.0,"shares_owned_after_display":"6,575","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-11","filed_date":"2015-05-12","scope":"insider"},{"id":8825874,"accession":"0001209191-15-029047","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-029047","line_url":"/filing/0001209191-15-029047#line-4","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001547658","owner_name":"Baird William D III","owner_display_name":"Baird William D III","owner_url":"/insider/0001547658","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15235.0,"shares_display":"15,235","price_per_share":11.506,"price_display":"11.51","price_state":"stated","total_value":175293.91,"total_display":"175,293.91","total_whole":"175,294","shares_owned_after":100000.0,"shares_owned_after_display":"100,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-20","filed_date":"2015-03-24","scope":"insider"},{"id":6494826,"accession":"0001209191-14-071251","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-071251","line_url":"/filing/0001209191-14-071251#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001547658","owner_name":"Baird William D III","owner_display_name":"Baird William D III","owner_url":"/insider/0001547658","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":80000.0,"total_display":"80,000.00","total_whole":"80,000","shares_owned_after":100000.0,"shares_owned_after_display":"100,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-25","filed_date":"2014-11-25","scope":"insider"},{"id":6494824,"accession":"0001209191-14-071251","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-071251","line_url":"/filing/0001209191-14-071251#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001547658","owner_name":"Baird William D III","owner_display_name":"Baird William D III","owner_url":"/insider/0001547658","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":80000.0,"total_display":"80,000.00","total_whole":"80,000","shares_owned_after":110000.0,"shares_owned_after_display":"110,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-25","filed_date":"2014-11-25","scope":"insider"},{"id":6272050,"accession":"0001209191-14-062132","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-062132","line_url":"/filing/0001209191-14-062132#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001547658","owner_name":"Baird William D III","owner_display_name":"Baird William D III","owner_url":"/insider/0001547658","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":70000.0,"total_display":"70,000.00","total_whole":"70,000","shares_owned_after":100000.0,"shares_owned_after_display":"100,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-03","filed_date":"2014-10-06","scope":"insider"},{"id":6272047,"accession":"0001209191-14-062132","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-062132","line_url":"/filing/0001209191-14-062132#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001547658","owner_name":"Baird William D III","owner_display_name":"Baird William D III","owner_url":"/insider/0001547658","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":70000.0,"total_display":"70,000.00","total_whole":"70,000","shares_owned_after":110000.0,"shares_owned_after_display":"110,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-03","filed_date":"2014-10-06","scope":"insider"},{"id":6272020,"accession":"0001209191-14-060722","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-060722","line_url":"/filing/0001209191-14-060722#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001547658","owner_name":"Baird William D III","owner_display_name":"Baird William D III","owner_url":"/insider/0001547658","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25311.0,"shares_display":"25,311","price_per_share":6.0887,"price_display":"6.09","price_state":"stated","total_value":154111.0857,"total_display":"154,111.09","total_whole":"154,111","shares_owned_after":100000.0,"shares_owned_after_display":"100,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-29","filed_date":"2014-10-01","scope":"insider"},{"id":6272018,"accession":"0001209191-14-060722","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-060722","line_url":"/filing/0001209191-14-060722#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001547658","owner_name":"Baird William D III","owner_display_name":"Baird William D III","owner_url":"/insider/0001547658","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25311.0,"shares_display":"25,311","price_per_share":6.0887,"price_display":"6.09","price_state":"stated","total_value":154111.0857,"total_display":"154,111.09","total_whole":"154,111","shares_owned_after":125311.0,"shares_owned_after_display":"125,311","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-29","filed_date":"2014-10-01","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":37,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":34,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":37},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001860782","name":"2seventy bio, Inc.","url":"/issuer/0001860782","role":"Director, Officer (President and CEO)","n_filings":13,"first_seen":"2022-01-11","last_seen":"2025-03-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001293971","name":"bluebird bio, Inc.","url":"/issuer/0001293971","role":"Officer (Chief Financial Officer)","n_filings":4,"first_seen":"2020-02-18","last_seen":"2021-02-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001178879","name":"AMICUS THERAPEUTICS INC","url":"/issuer/0001178879","role":"Officer (Chief Financial Officer)","n_filings":14,"first_seen":"2014-10-01","last_seen":"2018-10-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001547658","retrieved_at":"2026-08-24T09:53:39+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}